Related Experiment Video
Updated: Sep 15, 2025

10:28
Open-Source Real-Time Closed-Loop Electrical Threshold Tracking for Translational Pain Research
Published on: April 21, 2023
1.4K
An approach to targeting Nav1.7 for pain sensations
The Journal of Clinical Investigation
|July 15, 2025
Summary
Researchers discovered fibroblast growth factor 13 (FGF13) increases Nav1.7 channel activity and pain. A new compound, PW164, selectively targets FGF13 and Nav1.7, offering a promising strategy for nonaddictive pain relief.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Pain management is a significant challenge due to limited efficacy and side effects of current treatments.
- The Nav1.7 voltage-gated sodium channel is a key target for developing nonaddictive analgesics.
- Developing effective Nav1.7 blockers has proven difficult.
Purpose of the Study:
- To identify novel strategies for modulating Nav1.7 channel activity.
- To investigate the role of intrinsic modulators in nociceptor excitability and pain.
- To discover new therapeutic targets for pain management.
Main Methods:
- Identification of fibroblast growth factor 13 (FGF13) as a regulator of Nav1.7.
- Assessment of FGF13's effect on Nav1.7 currents and nociceptor excitability.
- Screening for and identification of a selective FGF13-Nav1.7 attenuator (PW164).
Main Results:
- Fibroblast growth factor 13 (FGF13) was identified as a factor that increases Nav1.7 channel activity, nociceptor excitability, and pain.
- Compound PW164 demonstrated selective attenuation of FGF13-mediated Nav1.7 activity.
- PW164 exhibited significant analgesic activity in preclinical models.
Conclusions:
- Targeting intrinsic modulators of Nav1.7, such as FGF13, represents a novel therapeutic strategy for pain.
- Compound PW164 shows potential as a nonaddictive analgesic by selectively inhibiting the FGF13-Nav1.7 pathway.
- These findings open new avenues for developing effective pain management therapies.
More Related Videos
Related Concept Videos
Nociception
29.5K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.5K
Pain
632
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
632
Local Anesthetics: Differential Sensitivity of Nerve Fibers
940
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
940
Thermosensation
31.8K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
31.8K
Analgesia and Pain Management
811
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
811

